It’s Hard to Be Too Bearish, Analyst Ian Harnett Says

Intellia Therapeutics Inc earnings beat by $0.10, revenue topped estimates

Investing.com · News 11m ago

H.C. Wainwright cuts Tempus AI stock price target to $64 on wider losses

Investing.com · News 12m ago

eXp World Holdings misses earnings despite revenue beat

Investing.com · News 12m ago

Guggenheim cuts Shake Shack stock price target on weak sales

Investing.com · News 12m ago

Guggenheim lowers DraftKings stock price target to $35 on model update

Investing.com · News 12m ago

Cantor Fitzgerald lowers LTC Properties stock price target on strategy shift

Investing.com · News 12m ago

H.C. Wainwright raises Artiva Biotherapeutics price target to $35

Investing.com · News 12m ago

H.C. Wainwright raises UroGen Pharma stock price target to $45

Investing.com · News 12m ago

H.C. Wainwright cuts CytomX stock price target on trial data

Investing.com · News 12m ago

How a Jet Fuel Supply Crunch Threatens Summer Flights

Bloomberg · Markets 15m ago